Discovery and structure-activity relationship of pyrrolo[2,1-f][1,2,4]triazines as inhibitors of phosphatidylinositol 3-kinase δ (PI3Kδ) for the treatment of immunological disorders

被引:0
|
作者
Shi, Qing [1 ]
Marcoux, David [1 ]
Liu, Qingjie [1 ]
Batt, Douglas [1 ]
Cornelius, Lyndon [1 ]
Srivastava, Anurag [1 ]
Cherney, Robert [1 ]
Qin, Lan-ying [1 ]
Ruan, Zheming [1 ]
Neels, James [1 ]
Bhide, Rajeev [1 ]
Li, Ling [1 ]
Bertrand, Myra Beaudoin [1 ]
Gong, Hua [1 ]
Watterson, Scott [1 ]
Pan, Jie [1 ]
Tang, Huaping [1 ]
Fan, Jingsong [1 ]
Yarde, Melissa [1 ]
Cvijic, Mary Ellen [1 ]
Obermeier, Mary [1 ]
Fura, Aberra [1 ]
Weigelt, Carolyn [1 ]
Galella, Michael [1 ]
Sack, Jack [1 ]
Muckelbauer, Jodi [1 ]
Gillooly, Kathleen [1 ]
McIntyre, Kim [1 ]
Ruan, Qian [1 ]
Poss, Michael [1 ]
Hynes, John [1 ]
Macor, John [1 ]
Carter, Percy [1 ]
Ruepp, Stefan [1 ]
Schieven, Gary [1 ]
Tino, Joseph [1 ]
机构
[1] Bristol Myers Squibb, Princeton, NJ USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
36
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure-Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives
    Nishimura, Nobuko
    Siegmund, Aaron
    Liu, Longbin
    Yang, Kevin
    Bryan, Marian C.
    Andrews, Kristin L.
    Bo, Yunxin
    Booker, Shon K.
    Caenepeel, Sean
    Freeman, Daniel
    Liao, Hongyu
    McCarter, John
    Mullady, Erin L.
    San Miguel, Tisha
    Subramanian, Raju
    Tamayo, Nuria
    Wang, Ling
    Whittington, Douglas A.
    Zalameda, Leeanne
    Zhang, Nancy
    Hughes, Paul E.
    Norman, Mark H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4735 - 4751
  • [32] Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections
    McPhail, Jacob A.
    Burke, John E.
    DRUGGABLE LIPID SIGNALING PATHWAYS, 2020, 1274 : 203 - 222
  • [33] Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors
    Wang, Lan
    Stanley, Mark
    Boggs, Jason W.
    Crawford, Terry D.
    Bravo, Brandon J.
    Giannetti, Anthony M.
    Harris, Seth F.
    Magnuson, Steven R.
    Nonomiya, Jim
    Schmidt, Stephen
    Wu, Ping
    Ye, Weilan
    Gould, Stephen E.
    Murray, Lesley J.
    Ndubaku, Chudi O.
    Chen, Huifen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4546 - 4552
  • [34] Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry
    Song, Yu'ning
    Zhan, Peng
    Zhang, Qingzhu
    Liu, Xinyong
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (08) : 1528 - 1548
  • [35] Design, synthesis, and evaluation of pyrrolo[2,1-f][1,2,4]triazine derivatives as novel hedgehog signaling pathway inhibitors
    Xin, Minhang
    Zhang, Liandi
    Tang, Feng
    Tu, Chongxing
    Wen, Jun
    Zhao, Xinge
    Liu, Zhaoyu
    Cheng, Lingfei
    Shen, Han
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1429 - 1440
  • [36] Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3-Kinase (PI3K)
    Van Dort, Martian E.
    Hong, Hao
    Wang, Hanxiao
    Nino, Charles A.
    Lombardi, Rachel L.
    Blanks, Avery E.
    Galban, Stefanie
    Ross, Brian D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (06) : 2512 - 2522
  • [37] Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors
    Caballero, Julio
    Quiliano, Miguel
    Alzate-Morales, Jans H.
    Zimic, Mirko
    Deharo, Eric
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2011, 25 (04) : 349 - 369
  • [38] Discovery of pyrrolo[2,1-f][1,2,4]triazine C5-ketones as potent, orally active inhibitors of tropomyosin-related kinases
    Fink, Brian E.
    Kim, Soong-Hoon
    Zhao, Yufen
    Wittman, Mark
    Tokarski, John
    Obermeier, Mary
    Gottardis, Marco
    McDevitt, Theresa
    You, Dan
    Lorenzi, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [39] Pyrrolo[2,1-f][1,2,4] triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle
    Ott, Gregory R.
    Favor, David A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (18) : 4238 - 4246
  • [40] Makorin-2 is a neurogenesis inhibitor downstream of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signal
    Yang, Pai-Hao
    Cheung, William K. C.
    Peng, Ying
    He, Ming-Liang
    Wu, Guo-Qing
    Xie, Dan
    Jiang, Bing-Hua
    Huang, Qiu-Hua
    Chen, Zhu
    Lin, Marie C. M.
    Kung, Hsiang-Fu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (13) : 8486 - 8495